期刊文献+

子宫内膜癌中PTEN蛋白、P-AKT蛋白的表达及意义 被引量:10

PTEN protein expression and significance of P-AKTprotein in endometrial carcinoma
下载PDF
导出
摘要 目的:检测子宫内膜癌组织中PTEN蛋白及P-AKT蛋白表达并探讨其意义。方法:采用免疫组织化学法检测66例子宫内膜癌、28例正常子宫内膜组织中PTEN蛋白及P-AKT的表达。结果:子宫内膜癌组织中PTEN蛋白为缺失表达,高于正常子宫内膜组织(P<0.05),而且PTEN表达在G1级肿瘤高于G2、G3级(P<0.05),PTEN蛋白缺失率与肿瘤组织类型有关(P<0.05),与肌层浸润、淋巴结转移及病理分期无明显关系(P>0.05)。子宫内膜癌组织中P-AKT蛋白表达为高表达,P-AKT的表达与肿瘤组织学分级、病理学分期、有无淋巴结转移以及肿瘤浸润子宫肌层深度显著相关(P<0.05),其表达与组织学类型无关(P>0.05)。P-AKT与PTEN的表达呈明显负相关。结论:PTEN表达缺失与临床病理参数无关,蛋白表达缺失常发生细胞分化较差的子宫内膜癌。PTEN蛋白表达缺失与P-AKT表达水平有关。 Objective:To detect endometrial carcinoma PTEN protein and the expression of P -AKT protein and study its significance. Methods: Immunohistochemical assay was used for the detection of PTEN protein and P - AKT in 66 cases of endometrial carcinoma, 28 cases of normal endometrial tissue. Results: Endometrial carcinoma tissue in PTEN protein expression was loss, higher than that in normal endometrial tissue (P 〈 0.05 ), and the PTEN expres- sion in G~ level was higher than that of G2, G3 tumor(P 〈 0.05 ), PTEN protein loss rate and tumor tissue types (P 〈 0.05 ) , and myometrial invasion, lymph node metastasis and pathological staging had no significant relationship ( P 〉 0. 05 ). Endometrial carcinoma expression of P - AKT protein expression, the expression of P - AKT and tumor histo- logical grade, pathological stage, without lymph node metastasis and tumor infiltrating the myometrium depth were sig- nificantly related( P 〈 0.05 ), and its expression was associated with histologic types( P 〉 0.05 ). P- AKT and FFEN expression was significantly negative correlated. Conclusion: PTEN expression and clinical pathology parameters are unrelated with protein loss. Expression loss of PTEN protein is related with the expression levels of P - AKT.
出处 《现代肿瘤医学》 CAS 2013年第3期633-635,共3页 Journal of Modern Oncology
关键词 子宫内膜肿瘤 PTEN P-AKT endometrial neoplasms PTEN P - AKT
  • 相关文献

参考文献17

  • 1Parenti A,Leo G,Porzionato A,et al. Expression of survivin,p53,and caspase 3 in Barrettr s esophagus carcinogenesis [ J ]. HumPathol,2006,37: 16 -22.
  • 2Li J,Yen C,Liaw D,et al. PTEN,a putative protein tyrosine phos-phatase genemutated in human brain,breast and prostate cancer[J]. Science, 1997,275:1943 -1947.
  • 3魏松锋,黄亮,张艳,程文元,高明.PTEN、Smad4在肿瘤发生、发展中作用的研究进展[J].现代肿瘤医学,2011,19(2):376-379. 被引量:7
  • 4Erkanli S, Kayaselcuk F, Kuscu E, et al. Expression of survivin,PTEN and p27 in normal hyperp lastic,and carcinomatous endometrium[ J]. Int J Gynecol Cancer,2006,16(3) :1412 - 1418.
  • 5Han SY,Kato H,Kato S,et al. Function evaluation of PTEN mis-sense mutations using in viro phosphoinositide phosphatase assay[J]. Cancer Res,2006,60( 12) :3147 -3151.
  • 6薛玲玲,何涛.子宫内膜中PTEN、p16蛋白的表达及临床意义[J].现代肿瘤医学,2010,18(3):545-547. 被引量:3
  • 7Cerezo L,Cardenes H,Michael H. Molecularalterations in the path-ogenesis of endometrial adenocarcinoma. Therapeutic implications[J] . Clin Trains Oncol,2006,8 (4) :231 -241.
  • 8黄海辉,梁后杰,胡绍毅,边志衡,何建明.磷脂酰肌醇3激酶信号通路影响细胞凋亡在肺腺癌A549细胞群集耐药中的作用[J].第三军医大学学报,2004,26(9):756-758. 被引量:8
  • 9Ruggeri BA,Huang L, Wood M,et al. Amplification and overex -pression of the AKT2 oncogene in a subset of human pancreaticductal adenocarcinomasf J]. Molcarcinog, 1998,21(2) :81 -86.
  • 10Yuan ZQ,Sun M,Feldman RI,et al. Frequent activation of AKT2and induction of apoptosis by inhibition of phosphoinositide - 3 -OH kinase/Akt pathway in human ovarian cancer[ J] , Oncogene,2000,19(19)-.2324 -2330.

二级参考文献55

共引文献41

同被引文献124

  • 1胡莉.PTEN和P53在子宫内膜癌中的表达及意义[J].中国老年学杂志,2014,34(11):2937-2939. 被引量:2
  • 2俞梅,沈铿,杨佳欣,黄惠芳,吴鸣,潘凌亚,郎景和,连利娟.高分化子宫内膜样癌及子宫内膜重度不典型增生患者孕激素治疗的临床分析[J].中华妇产科杂志,2006,41(4):242-245. 被引量:28
  • 3虞斌,许培箴.子宫内膜癌肿瘤标志物的研究进展[J].现代生物医学进展,2006,6(11):139-141. 被引量:3
  • 4南芳芳,姜洁,夏敏,董,冯进波.RASSF1 A基因在子宫内膜癌组织中的表达及意义[J].山东大学学报(医学版),2007,45(1):94-96. 被引量:5
  • 5Steelman LS, Chappell WH, Abrams SL, et al. Roles of the Raf/ MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging [J]. Aging (Albany NY) , 2011,3(2) :192-222.
  • 6Steck PA, Pershouse MA, Tasser SA, et al. Identification of a can-didate tumor suppressor gene MMAC at chromosome 10@3.3 that is mutated in multiple advanced cancers [J]. Nat Genet, 1997,15 (4) :357-362.
  • 7Khwaja A. PI3K as a target for therapy in haematologicalmalignan- cies[ J]. Curr Top Microbiol Immunol, 2010, 347 (47) : 169-188.
  • 8Goo CK, Lim HY, Ho QS, et al. PTEN/Akt signaling controls mi- tochondrial respiratory capacity through 4E BP1 [ J ]. PLoS One, 2012,7(9) :e45806.
  • 9Wang X, Jiang X. Post-translational regulation of PTEN :J}. Oncogene, 2008, 27 (41): 5454-5463.
  • 10Steck PA, Pershouse MA, Tasser SA, et al. Identification of a candidate tumor suppressor gene MMAC at chromosome 10q23.3 that is mutated in multiple advanced cancers[J]. Nat Genet, 1997, 15 (4):357-362.

引证文献10

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部